Psychiatry and Neurology, Neurology · Blaine, MN
NPI
1336333509
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
11091 Ulysses St, Suite 100
Blaine, MN, 55434
Phone (612) 879-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$310K
21,183 services
Medicare patients, 2024
462
Average age 67
Drug cost, 2024
$2.1M
2,484 prescriptions
Company payments, 2025
$27K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shelly L Larson-Peters was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,500 times for 12 patients. In total Shelly L Larson-Peters billed 21,183 services in 48 codes, and Medicare paid $310K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,500 | 12 | $4.82 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 380 | 25 | $0.08 | $29.56 |
| 99215 Office E&M - Established | Office | 215 | 199 | $117.86 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 154 | 139 | $10.88 | $1,675 |
| 99214 Office E&M - Established | Office | 137 | 128 | $85.26 | $12K |
| 99205 Office E&M - New | Office | 62 | 62 | $154.05 | $9,551 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 56 | 41 | $23.98 | $1,343 |
| 64615 Musculoskeletal | Office | 43 | 22 | $110.56 | $4,754 |
| 96365 Intravenous Infusion, Hydration | Office | 34 | 15 | $49.20 | $1,673 |
| 20553 Musculoskeletal | Office | 30 | 22 | $36.61 | $1,098 |
| 95886 Electrical Nerve Conductivity | Office | 27 | 18 | $70.55 | $1,905 |
| 64405 Musculoskeletal | Office | 23 | 18 | $43.05 | $990 |
| 99204 Office E&M - New | Office | 16 | 16 | $107.63 | $1,722 |
| 64450 Musculoskeletal | Office | 15 | 11 | $82.09 | $1,231 |
| 99213 Office E&M - Established | Office | 14 | 14 | $65.68 | $919 |
By year: 2022 $205K for 10,859 services; 2023 $175K for 11,679 services; 2024 $310K for 21,183 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shelly L Larson-Peters prescribed most often to Medicare patients was Gabapentin, with 238 prescriptions and refills. In total Shelly L Larson-Peters wrote 2,484 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 238 | 510 | 79 | $5,951 |
| Copaxone Glatiramer Acetate | 110 | 112 | 12 | $660K |
| Levetiracetam Generic | 106 | 263 | 30 | $3,821 |
| Sumatriptan Succinate Generic | 83 | 85 | 21 | $790 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 80 | 80 | 14 | $2,163 |
| Tizanidine Hcl Generic | 77 | 125 | 16 | $740 |
| Donepezil Hcl Generic | 76 | 176 | 27 | $1,557 |
| Baclofen Generic | 71 | 159 | 32 | $1,693 |
| Pregabalin Generic | 69 | 105 | 17 | $1,622 |
| Topiramate Generic | 65 | 163 | 23 | $1,318 |
| Modafinil Generic | 64 | 73 | 11 | $17K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 63 | 149 | 21 | $3,033 |
| Glatopa Glatiramer Acetate | 61 | 79 | Under 11 | $142K |
| Glatiramer Acetate Generic | 59 | 61 | Under 11 | $125K |
| Propranolol Hcl Er Propranolol Hcl | 51 | 97 | 16 | $1,422 |
Brand drugs: - claims; generic drugs: 2,115 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shelly L Larson-Peters $27K ($27K in general payments such as food, travel and fees) from 3 companies. The largest payer was TG Therapeutics, Inc. with $19K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.